Immunome Inc（IMNM）價格預測IMNMImmunome Inc

Alphio's IMNM stock price prediction model matches the current Immunome Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.75 (-1.34%). The 1-week path is $17.91 (-0.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Immunome Inc is a good buy right now, trading at $17.99, significantly below the analyst price targets ranging from $24 to $37. The company has a strong cash position of $582.7 million, which is expected to fund operations into 2028, providing stability for future growth. Additionally, the recent FDA acceptance of the varegacestat application indicates potential for revenue growth, especially with the projected 84% reduction in disease progression risk shown in clinical trials. However, the main risk is the negative earnings trend, with a projected EPS of -0.67 for the next earnings date, which could impact investor sentiment.

Immunome Inc (IMNM) last closed at $17.99, losing -1.48%. These facts feed the 1-day and 1-week IMNM price prediction above.